Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Comparative bioavailability of betahistine tablet formulations administered in healthy subjects|
De Nucci, G
|Abstract:||Objective: To assess the comparative bioavailability of two formulations (16 mg tablet) of betahistine (CAS 5579-84-0) in healthy volunteers of both sexes. Methods: The study was conducted using an open, randomized, two-period crossover design with a 1-week washout interval. Plasma samples were obtained for up to 36 h post dose. Plasma 2-pyridylacetic acid concentrations were analyzed by liquid chromatography coupled with tandem mass spectrometry (LC-MS-MS) with positive ion electrospray ionization using multiple reaction monitoring (MRM). From the 2-pyridylacetic acid plasma concentration vs. time curves, the following pharmacokinetic parameters were obtained for AUC(last) and C(max). Results: The limit of quantification was 4 ng/mL for plasma 2-pyridylacetic acid analysis. The geometric mean and 90 To confidence interval (CI) of test/reference percent ratios were: 98.94% (92.21% - 106.16%) for C(max), 95.42% (91.74% - 99.25%) for AUC(last). Conclusion: Since the 90% CI for C(max) and AUCs ratios were all within the 80-125 % interval proposed by the US Food and Drug Administration Agency, it was concluded that the test formulation is bioequivalent to the reference for both the rate and the extent of absorption.|
|Subject:||Betahistine, bioequivalence, pharmacokinetics|
|Editor:||Ecv-editio Cantor Verlag Medizin Naturwissenschaften|
|Citation:||Arzneimittel-forschung-drug Research. Ecv-editio Cantor Verlag Medizin Naturwissenschaften, v. 60, n. 7, n. 440, n. 444, 2010.|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.